Lacktman, Ferrante Discuss Proposed Legislation Aimed at Combatting Substance Abuse
05 March 2018
mHealthIntelligence
Partner Nate Lacktman and Senior Counsel Thomas Ferrante were quoted in an mHealthIntelligence article, “Congress Turns to Telemedicine to Take on Substance Abuse Epidemic,” about two bills pending in Congress that would ease restrictions on the prescribing of controlled substances to patients in telehealth-based drug treatment programs.
Lacktman and Ferrante said current federal law does not per se prohibit the use of telemedicine to prescribe controlled substances, and that a provider may do so if he or she has conducted at least one in-person exam of the patient or meets a ‘practice of telemedicine’ exception to the law’s in-person exam requirement. The problem, they said, is that the ‘practice of telemedicine’ exceptions in the law are very narrow, highly technical, and simply outdated.
“The practice of telemedicine has evolved exponentially in the decade since the [federal law] was passed, and the regulations fail to account for how legitimate telemedicine services are delivered today,” the pair said. “For that reason, the exceptions do not easily align with direct-to-patient service models frequently sought by patients in areas such as telepsychiatry or substance use disorder treatment. In addition, there is a nationwide shortage of psychiatrists and board certified substance abuse addiction specialists, coupled with the nation’s tragic opioid crisis, making telemedicine services an attractive resource.”
Lacktman and Ferrante’s quotes were sourced from their recent Health Care Law Today blog post, which can be found here.
Lacktman and Ferrante said current federal law does not per se prohibit the use of telemedicine to prescribe controlled substances, and that a provider may do so if he or she has conducted at least one in-person exam of the patient or meets a ‘practice of telemedicine’ exception to the law’s in-person exam requirement. The problem, they said, is that the ‘practice of telemedicine’ exceptions in the law are very narrow, highly technical, and simply outdated.
“The practice of telemedicine has evolved exponentially in the decade since the [federal law] was passed, and the regulations fail to account for how legitimate telemedicine services are delivered today,” the pair said. “For that reason, the exceptions do not easily align with direct-to-patient service models frequently sought by patients in areas such as telepsychiatry or substance use disorder treatment. In addition, there is a nationwide shortage of psychiatrists and board certified substance abuse addiction specialists, coupled with the nation’s tragic opioid crisis, making telemedicine services an attractive resource.”
Lacktman and Ferrante’s quotes were sourced from their recent Health Care Law Today blog post, which can be found here.
People
Related News
27 August 2024
In the News
Samuel Goldstick Assesses Data Privacy Challenges for Automakers
Foley & Lardner LLP partner Samuel Goldstick underscored how disclosure can help automakers reduce legal risk in the Automotive Dive article, "Automakers face growing data privacy challenges, experts say."
26 August 2024
In the News
Judith Waltz Quoted on Inflation Reduction Act, Pharma Impact
Foley & Lardner LLP partner Judith Waltz is quoted in the PharmaVoice article, "Pharmas’ IRA court losses mount. They keep pursuing them."
20 August 2024
In the News
Kevin Hyde Featured in Q&A on Jacksonville Legal Market – 'The outlook is good'
Foley & Lardner LLP partner Kevin Hyde is featured in a Capital Analytics Associates Q&A on the major achievements of Foley's Jacksonville office, key trends in the legal market, and the firm's commitment to its talent and client service.